🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Solitary Bone Plasmacytoma

Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration NCT07115667Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: BCMA/CD3 bispecific antibody (CM336) Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma NCT05248633Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: radiotherapy, Bortezomib Injection, Lenalidomide, Dexamethasone GR1803 Injection in Patients With RRMM NCT06952075Phase 21 site📍 Tianjin Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Tests: GR1803 SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial NCT06863584Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Lenalidomide (Revlimid), SBRT
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy